1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249.

2. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687–696.

3. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst 2017;109:djw322..

4. Sung JJY, Chiu HM, Jung KW, et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am J Gastroenterol 2019;114:322–329.

5. Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68:1820–1826.

6. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–281.

7. Enwerem N, Cho MY, Demb J, et al. Systematic review of prevalence, risk factors, and risk for metachronous advanced neoplasia in patients with young-onset colorectal adenoma. Clin Gastroenterol Hepatol 2021;19:680–689.

8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759–767.

9. Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr 2021;30:81–92.

10. Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians?: redefining obesity for Asians. Public Health Nutr 2009;12:497–506.

11. World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney (AU): Health Communications Australia, 2000. 12. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.

13. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844–857.

14. Choe JW, Chang HS, Yang SK, et al. Screening colonoscopy in asymptomatic average-risk Koreans: analysis in relation to age and sex. J Gastroenterol Hepatol 2007;22:1003–1008.

15. Park HW, Byeon JS, Yang SK, et al. Colorectal neoplasm in asymptomatic average-risk Koreans: the KASID Prospective Multicenter Colonoscopy Survey. Gut Liver 2009;3:35–40.

16. Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. J Gastroenterol Hepatol 2010;25:519–525.

17. Kim HS, Baik SJ, Kim KH, Oh CR, Lee SI. Prevalence and risk factors of colorectal adenoma in 14,932 Koreans undergoing screening colonoscopy. Korean J Gastroenterol 2013;62:104–110.

18. Kwak JY, Kim KM, Yang HJ, et al. Prevalence of colorectal adenomas in asymptomatic young adults: a window to early intervention? Scand J Gastroenterol 2016;51:731–738.

19. Kim NH, Jung YS, Yang HJ, et al. Prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults (20–39 years old). Clin Gastroenterol Hepatol 2019;17:115–122.

20. Subramanian V, Mannath J, Hawkey CJ, Ragunath K. High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy 2011;43:499–505.

21. Adler A, Aminalai A, Aschenbeck J, et al. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol 2012;10:155–159.

22. Waldmann E, Britto-Arias M, Gessl I, et al. Endoscopists with low adenoma detection rates benefit from high-definition endoscopy. Surg Endosc 2015;29:466–473.

23. Gupta AK, Samadder J, Elliott E, Sethi S, Schoenfeld P. Prevalence of any size adenomas and advanced adenomas in 40- to 49-year-old individuals undergoing screening colonoscopy because of a family history of colorectal carcinoma in a first-degree relative. Gastrointest Endosc 2011;74:110–118.

24. Lee SE, Jo HB, Kwack WG, Jeong YJ, Yoon YJ, Kang HW. Characteristics of and risk factors for colorectal neoplasms in young adults in a screening population. World J Gastroenterol 2016;22:2981–2992.

25. Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc 2010;72:480–489.

26. Koo JE, Kim KJ, Park HW, et al. Prevalence and risk factors of advanced colorectal neoplasms in asymptomatic Korean people between 40 and 49 years of age. J Gastroenterol Hepatol 2017;32:98–105.

27. Santucci C, Boffetta P, Levi F, La Vecchia C, Negri E, Malvezzi M. Colorectal cancer mortality in young adults is rising in the United States, Canada, United Kingdom, and Australia but not in Europe and Asia. Gastroenterology 2021;160:1860–1862.

28. GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13–27.

29. Im JP, Kim D, Chung SJ, et al. Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy. Gastrointest Endosc 2018;88:119–127.

30. Nagata N, Sakamoto K, Arai T, et al. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma. Int J Cancer 2014;135:2273–2281.

31. Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol 2010;105:178–187.

32. World Health Organization. In : Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation; Geneva. 8–11 December 2008; Geneva (CH): World Health Organization, 2011. 33. Seo MH, Kim YH, Han K, et al. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance Service health checkup data 2006–2015. J Obes Metab Syndr 2018;27:46–52.

34. Tie G, Yan J, Khair L, et al. Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and γδ T cells from hematopoietic stem cells. Cancer Res 2017;77:2351–2362.

35. Matsui S, Okabayashi K, Tsuruta M, et al. Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis. Cancer Sci 2019;110:2156–2165.

36. Di Franco S, Bianca P, Sardina DS, et al. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun 2021;12:5006.

37. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004;308:66–72.

38. Ye YN, Wu WK, Shin VY, Cho CH. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 2005;519:52–57.

39. Wong HP, Li ZJ, Shin VY, et al. Effects of cigarette smoking and restraint stress on human colon tumor growth in mice. Digestion 2009;80:209–214.